Robert Günzel, (Greensocs Ltd and TU Braunschweig,) Herve Alexanian, (Sonics Inc) reprinted with permission by OCP-IP - (C) Copyright OCP-IP OSCI has recently ...
TLM-001 is under clinical development by Therillume and currently in Phase III for Glioblastoma Multiforme (GBM). According to GlobalData, Phase III drugs for Glioblastoma Multiforme (GBM) have a 29% ...
Transformation of data and control from the protocol interface specification, along with translation of the timing and the sequencing in the protocol, as well as generation of appropriate checkers for ...